[Recommendations in the empiric anti-infective agents of intra-abdominal infection]

Cir Esp. 2010 Feb;87(2):63-81. doi: 10.1016/j.ciresp.2009.09.014. Epub 2009 Nov 22.
[Article in Spanish]

Abstract

A significant number of patients with abdominal infection develop advanced stages of infection and mortality is still above 20%. Failure is multifactorial and is associated with an increase of bacterial resitance, inappropriate empirical treatment, a higher comorbidity of patients and poor source control of infection. These guidelines discuss each of these problems and propose measures to avoid the failure based on the best current scientific evidence.

Publication types

  • Consensus Development Conference
  • English Abstract

MeSH terms

  • Abdomen*
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / complications
  • Bacterial Infections / diagnosis
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / microbiology
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Humans
  • Postoperative Complications / drug therapy
  • Postoperative Complications / microbiology

Substances

  • Anti-Bacterial Agents